Resultados de su búsqueda "Nose Bleeds".
More than half of people with a rare life-threatening bleeding condition received lasting relief from an experimental antibody treatment, clinical trial results show.
Ianalumab, a monoclonal antibody, helped patients with immune thrombocytopenia (ITP) maintain safe platelet counts without serious bleeding episodes for at least a year, according to results published Dec. 9 in
Nuestra compromiso a la atención del paciente y su salud es nuestra primera prioridad aquí en Case Drug Company.
Nosotros creemos en proveerle servicios y productos de calidad.
2025 © Reservados todos los derechos. Políticas de Privacidad
